Log in
Enquire now

List of A&G Pharmaceutical, Inc. patents

List of A&G Pharmaceutical, Inc. patents
List of Vasona Networks patents
List of OncoImmune patents
List of Lindar Corporation patents
List of companies in Eurostars's investment portfolio
Companies in the Packaging and labeling industry
Patents where
Current Assignee
Name
is
‌
A&G Pharmaceutical, Inc.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7560095 Cancer specific monoclonal antibodies

Patent 7560095 was granted and assigned to A&G Pharmaceutical, Inc. on July, 2009 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
7560095
July 14, 2009
‌
US Patent 11555074 Monoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitor and uses thereof

Patent 11555074 was granted and assigned to A&G Pharmaceutical, Inc. on January, 2023 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11555074
January 17, 2023
‌
US Patent 7674460 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists

Patent 7674460 was granted and assigned to A&G Pharmaceutical, Inc. on March, 2010 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
7674460
March 9, 2010
‌
US Patent 8088373 Autocrine growth factor receptor antibodies and methods

Patent 8088373 was granted and assigned to A&G Pharmaceutical, Inc. on January, 2012 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8088373
January 3, 2012
‌
US Patent 7651854 Methods for increasing the proliferation of B cells

Patent 7651854 was granted and assigned to A&G Pharmaceutical, Inc. on January, 2010 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
7651854
January 26, 2010
‌
US Patent 7815906 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists

Patent 7815906 was granted and assigned to A&G Pharmaceutical, Inc. on October, 2010 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
7815906
October 19, 2010
‌
US Patent 8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells

Patent 8007997 was granted and assigned to A&G Pharmaceutical, Inc. on August, 2011 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8007997
August 30, 2011
‌
US Patent 8911950 Methods and compositions for inhibiting the growth of hematopoietic malignant cells

Patent 8911950 was granted and assigned to A&G Pharmaceutical, Inc. on December, 2014 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8911950
December 16, 2014
‌
US Patent 7411045 Autocrine growth factor receptor antibodies and methods

Patent 7411045 was granted and assigned to A&G Pharmaceutical, Inc. on August, 2008 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
7411045
August 12, 2008
‌
US Patent 8512960 88kDa tumorigenic growth factor and antagonists

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8512960
August 20, 2013
‌
US Patent 6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy

Patent 6881548 was granted and assigned to A&G Pharmaceutical, Inc. on April, 2005 by the United States Patent and Trademark Office.

‌
A&G Pharmaceutical, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
6881548
April 19, 2005
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us